One striking finding of this study is that HHT could activate the TGF-β pathway, one of the most important pathways of epithelium-derived carcinoma, that is, an effective medicine for hematological malignancies could activate a very important pathway in solid carcinomas. This evidence concerns the gene TGFB1 and hematologic disorder.